ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES

Ligandrol Ameliorates High-Fat Diet- and Streptozotocin-Induced Type 2 Diabetes Mellitus and Prevents Pancreatic Islets Degeneration
Sugumar D, Ghosh R, Rymbai E, Chandrasekaran J, Krishnamurthy PT, P RS, Sahu S and Selvaraj D
Androgen therapy has been shown to alleviate type 2 diabetes mellitus (T2DM) but is also associated with severe side effects such as prostate cancer. The present study aims to identify the best hit selective androgen (AR) modulator by studies and then investigates its antidiabetic effects in high-fat diet- and streptozotocin (STZ)-induced T2DM male rat model. Molecular docking and molecular dynamics (MD) studies were carried out using Maestro 13.1 and Desmond (2023-2024). Cytotoxicity and insulin secretion were measured in MIN6 cell lines. T2DM was induced using high-fat diet (HFD) for 4 weeks, followed by single STZ (40 mg/kg, intraperitoneally). OneTouch Ultra glucometer was used to measure fasting blood glucose. Gene expression was determined using reverse transcription polymerase chain reaction. Histopathology was carried out using hematoxylin and eosin stain. Through molecular docking, we identify ligandrol as a potential hit. Ligandrol showed a good binding affinity (-10.74 kcal/mol). MD showed that ligandrol is stable during the 100 ns simulation. Ligandrol increases insulin secretion in a dose-dependent manner in 2 h. Ligandrol (0.3 and 1 mg/kg, orally) significantly decreased the body weight and fasting blood glucose levels compared with the HFD and STZ group. Gene expression showed that ligandrol significantly increased the AR-targeted gene, , compared with the HFD and STZ group. Histopathological staining studies showed that ligandrol prevents pancreatic islet degeneration compared with the HFD and STZ group. Our findings suggest that ligandrol's protective effect on pancreatic islets leading to its antidiabetic effect occurs through the activation of AR.
Novel Pharmaceutical Cocrystal Consisting of Chlorzoxazone and Nicotinamide: A New Promising Carrier for Solubility Augmentation
Sekhani A, Jha R and Shah PJ
A Time of Transition: Looking Back with Gratitude, Forward with Optimism
Melancon BJ
Unlocking Antioxidant-Anticancer Synergy: An Exploration of Therapeutic Bioactives from Methanolic Extracts of and Using HeLa Cell Line
Bhardwaj V, Kulkarni GT and Nagpal K
Polyherbal Antiacne Gel: Antibacterial Activity and Efficacy Evaluation Against
Gaur PK, Mishra R, Kaushik R, Verma KK, Kumar N and Lata K
Drug Repurposing Patent Applications: April-June 2024
Mucke HAM
A Concise Review on Effect of PEGylation on the Properties of Lipid-Based Nanoparticles
Krishnan J, Poomalai P, Ravichandran A, Reddy A and Sureshkumar R
MiR-22-3p Inhibits 5-Fluorouracil Resistance in Cholangiocarcinoma Cells Through PTEN/PI3K/AKT Axis
Zhang N and Zang L
Microsponges: Development, Characterization, and Key Physicochemical Properties
Qureshi S, Alavi SE and Mohammed Y
.
High-Throughput Methods for the Discovery of Small Molecule Modulators of Pancreatic Beta-Cell Function and Regeneration
McCarty SM, Clasby MC and Sexton JZ
A Perspective on Various Facets of Nanoemulsions and its Commercial Utilities
Mishra I, Mishra R, Dubey A and Dhakad PK
Exosomes: Key Players for Treatment of Cancer and Their Future Perspectives
Gupta R, Gupta J and Roy S
A Review on Molecular Docking As an Interpretative Tool for Molecular Targets in Disease Management
Sahu D, Rathor LS, Dwivedi SD, Shah K, Chauhan NS, Singh MR and Singh D
One of the most often utilized methods for drug discovery is molecular docking. With docking, one may discover new therapeutically relevant molecules by targeting the molecule and predicting the target-ligand interactions as well as different conformation of ligand at various positions. The prediction signifies the effectiveness of the molecule or the developed molecule having different affinity with target. Drug discovery plays an important role in the development of a new drug molecule of different moiety attached to it, which leads us in the management of several diseases. approach led us to identification of numerous diseases caused by virus, fungi, bacteria, protozoa, and other microorganisms that affect human health. By means of computational approach, we can categorize disease symptoms and use the drugs available for such types of warning signs. After the docking process, molecular dynamics computational technique helps in the simulation of the physical movement of atoms and molecules for a fixed period of time, giving a view of the dynamic evaluation of the system. This review is an attempt to illustrate the role of molecular docking in drug development.
Synthesis of Novel Acrylamide Graft Copolymer of Gum for the Stabilization of Melatonin Nanoparticles for Improved Therapeutic Effect: Optimization Using (3) Factorial Design
Sundram S, Dhiman N, Malviya R and Awasthi R
A Novel Gelling System of Quercetin/Sulfobutyl-Ether-β-Cyclodextrin Complex-Loaded Chitosan Nanoparticles for the Treatment of Vulvovaginitis
Maxwell A, Modi P, Sequeira K, Punja M and Lewis S
Synthesis, Antimicrobial Evaluation, and Studies of 2-Substituted-Phenyl-3-(5-Aryl/Heteroaryl Substituted Thiazol-2-yl) Thiazolidin-4-One Derivatives
Pawar S, Karan R, Hazarika S, Lal M, Rawal RK and Gupta PK
Latest Delivery Advancements of Lipid Nanoparticles for Cancer Treatment
Chauhan S and Nagpal K
Antidiabetic Evaluation of Root Bark Extract in Streptozotocin-Induced Type-2 Diabetes Model of Rats
Kumar R, Kumar N, Rajput SK, Mallan S, Kumar A, Rawat BS, Rangra NK and Singh S
Kigelia pinnata K. pinnata
Feature Engineering-Assisted Drug Repurposing on Disease-Drug Transcriptome Profiles in Gastric Cancer
Kırboğa KK and Rudrapal M
High-Throughput DNA-Encoded Libraries Affinity Selection Platform for Binder Identification with Solid Support Protein Immobilization
Rama-Garda R, Domínguez E, Loza MI, Lallena MJ, de Blas J, Toledo MÁ and Haro R
Beyond the Maze: Recent Advancements in Molecular and Cellular Tethered Drug Delivery Systems
Singh D